Pennant Group (PNTG) vs Starling Oncology (STLN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Over five years, PNTG leads with a +52.7% price change compared with -35.4% for STLN. Pennant Group is the larger company by market cap ($1.38 billion vs $655.3 million), about 2.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PNTG | STLN |
|---|---|---|
| Share price | $39.62 | $6.43 |
| Market cap | $1.38B | $655.32M |
| 1-day change | -0.84% | -2.28% |
| YTD return | — | +80.62% |
| 1-year return | — | +68.32% |
| 5-year return | +52.74% | -35.38% |
| P/E ratio (TTM) | 43.54 | — |
| Forward P/E | 24.96 | — |
| EPS (TTM) | $0.91 | $-0.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $42.74 | $7.13 |
| 52-week low | $22.26 | $2.32 |
| Distance from 52-week high | -7.30% | -9.82% |
| Average volume | 303.79K | 1.56M |
| Shares outstanding | 34.93M | 101.92M |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Pennant Group is about 2.1 times larger than Starling Oncology by market value ($1.38B vs $655.32M).
PNTG vs STLN FAQ
Which is bigger, Pennant Group or Starling Oncology?
Pennant Group (PNTG) is larger, with a market capitalization of $1.38B compared with $655.32M for Starling Oncology (STLN).
Are Pennant Group and Starling Oncology in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.